Sara Calattini

1.9k total citations
41 papers, 1.4k citations indexed

About

Sara Calattini is a scholar working on Ecology, Evolution, Behavior and Systematics, Immunology and Agronomy and Crop Science. According to data from OpenAlex, Sara Calattini has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ecology, Evolution, Behavior and Systematics, 14 papers in Immunology and 13 papers in Agronomy and Crop Science. Recurrent topics in Sara Calattini's work include T-cell and Retrovirus Studies (14 papers), Vector-Borne Animal Diseases (14 papers) and Animal Disease Management and Epidemiology (13 papers). Sara Calattini is often cited by papers focused on T-cell and Retrovirus Studies (14 papers), Vector-Borne Animal Diseases (14 papers) and Animal Disease Management and Epidemiology (13 papers). Sara Calattini collaborates with scholars based in France, United States and Cameroon. Sara Calattini's co-authors include Antoine Gessain, Alain Froment, Renaud Mahieux, Sébastien Alain Chevalier, Ali Saı̈b, Sylviane Bassot, Renan Duprez, Edouard Betsem, Spinello Antinori and Philippe Mauclère and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Sara Calattini

40 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sara Calattini

Since Specialization

Citations

This map shows the geographic impact of Sara Calattini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Calattini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Calattini more than expected).

Fields of papers citing papers by Sara Calattini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Calattini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Calattini. The network helps show where Sara Calattini may publish in the future.

Co-authorship network of co-authors of Sara Calattini

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Calattini. A scholar is included among the top collaborators of Sara Calattini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Calattini. Sara Calattini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IMMUNORARE ⁵ : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The B3 Thymomas and Thymic Carcinomas Cohort. 2025 ·Journal of Clinical Oncology ·M. Duruisseaux, Benjamin Besse, Nicolas Girard, Éric Dansin, Sophie Cousin, Julien Mazières, Ludovic Doucet, Anne Madroszyk, Laurent Greillier, Charles Ricordel, (unknown), Céline Mascaux, Cécile Vicier, Diégo Tosi, Sara Calattini, Vérane Schwiertz, Sylvie Bin, Fabien Subtil, Benoît You, (unknown)	0
2	Diagnostic value of hPG₈₀, as a new multi-cancer blood biomarker, in 16 different cancers: Results of the ONCOPRO prospective study. 2023 ·Journal of Clinical Oncology ·Benoît You, S. Couraud, Philippe Céruse, Lionel Badet, P. Paparel, Thomas Walter, Marielle Guillet, Philippe Merle, Charles‐André Philip, François Ducray, Mathieu Pioche, Lionel Karlin, Jean‐Christophe Lifante, Olivier Gléhen, Pierre‐Adrien Bolze, Marion Chauvenet, Carole Langlois‐Jacques, Fabien Subtil, Sara Calattini, Léa Payen	1
3	Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial 2023 ·The Lancet Haematology ·Christopher Melani, Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y. Song, Sara Calattini, Jun‐ichi Kawada, (unknown), Pratip K. Chattopadhyay, Mario Roederer, Andrea N. Lucas, Seth M. Steinberg, Elaine S. Jaffe, Jeffrey I. Cohen, Wyndham H. Wilson	1
4	Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors 2023 ·Cancer Chemotherapy and Pharmacology ·(unknown), Alicja Puszkiel, Michel Tod, Sara Calattini, Léa Payen, Jonathan Lopez, Jérôme Guitton, Vérane Schwiertz, Juliette Fontaine, Julien Péron, Denis Maillet, Sophie Tartas, Nathalie Bonnin, Olivier Colomban, (unknown), Gilles Freyer, Benoît You	2
5	Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept 2022 ·Cancers ·Xavier Rousset, Denis Maillet, (unknown), (unknown), Sara Calattini, Marie Brevet, (unknown), (unknown), (unknown), Jessica Garcia, Myriam Decaussin‐Petrucci, Julien Péron, Nazim Benzerdjeb, S. Couraud, Jean Viallet, Léa Payen	9
6	hPG80 et cancer : un nouveau biomarqueur sanguin en développement pour le suivi des patients 2022 ·Bulletin du Cancer ·Benoît You, Eric Assénat, Léa Payen, Thibault Mazard, Olivier Gléhen, Sara Calattini, Laurent Villeneuve, (unknown), Bérengère Vire, Marc Ychou	2
7	COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study 2021 ·Cancers ·Julien Péron, (unknown), Anne Conrad, Fanny Pineau, Sara Calattini, Gilles Freyer, David Pérol, Christophe Sajous, Maël Heiblig	10
8	A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status 2015 ·Molecular Therapy ·Floriane Fusil, Sara Calattini, Fouzia Amirache, Jimmy Mancip, Caroline Costa, Justin B. Robbins, Florian Douam, Dimitri Lavillette, Mansun Law, Thierry Defrance, Els Verhoeyen, François–Loïc Cosset	34
9	Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model 2015 ·Journal of Biological Chemistry ·Sara Calattini, Floriane Fusil, Jimmy Mancip, Viet Loan Dao Thi, Christelle Granier, Nicolas Gadot, Jean‐Yves Scoazec, Mirjam B. Zeisel, Thomas F. Baumert, Dimitri Lavillette, Marlène Dreux, François–Loïc Cosset	24
10	HTLV-2B Strains, Similar to Those Found in Several Amerindian Tribes, Are Endemic in Central African Bakola Pygmies 2011 ·The Journal of Infectious Diseases ·Philippe Mauclère, Philippe V. Afonso, Laurent Meertens, Sabine Plancoulaine, Sara Calattini, Alain Froment, Monique van Beveren, Guy de Thé, Lluís Quintana‐Murci, Renaud Mahieux, Antoine Gessain	39
11	Multiple retroviral infection by HTLV type 1, 2, 3 and simian foamy virus in a family of Pygmies from Cameroon 2010 ·Virology ·Sara Calattini, Edouard Betsem, Sylviane Bassot, Sébastien Alain Chevalier, Patricia Tortevoye, Richard Njouom, Renaud Mahieux, Alain Froment, Antoine Gessain	29
12	Is Real-Time Polymerase Chain Reaction (PCR) More Useful Than a Conventional PCR for the Clinical Management of Leishmaniasis? 2009 ·American Journal of Tropical Medicine and Hygiene ·Spinello Antinori, Sara Calattini, R. Piolini, Erika Longhi, Giovanna Bestetti, Antonio Cascio, Carlo Parravicini, Mario Corbellino	25
13	Simian Foamy Virus Transmission from Apes to Humans, Rural Cameroon 2007 ·Emerging infectious diseases ·Sara Calattini, Edouard Betsem, Alain Froment, Philippe Mauclère, Patricia Tortevoye, Christine Schmitt, Richard Njouom, Ali Saı̈b, Antoine Gessain	92
14	Prospective Observational Study of Fever in Hospitalized Returning Travelers and Migrants from Tropical Areas, 1997-2001 2006 ·Journal of Travel Medicine ·Spinello Antinori, Laura Galimberti, Erika Gianelli, Sara Calattini, Manuela Piazza, Paola Morelli, Mauro Moroni, Massimo Galli, Mario Corbellino	41
15	Detection and molecular characterization of foamy viruses in Central African chimpanzees of the Pan troglodytes troglodytes and Pan troglodytes vellerosus subspecies 2006 ·Journal of Medical Primatology ·Sara Calattini, Eric Nerrienet, Philippe Mauclère, Marie‐Claude Georges‐Courbot, Ali Saı̈b, Antoine Gessain	30
16	The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax 2006 ·Oncogene ·Sébastien Alain Chevalier, Laurent Meertens, Cynthia A. Pise-Masison, Sara Calattini, (unknown), (unknown), Meisheng Zhou, Antoine Gessain, Fatah Kashanchi, John Brady, Renaud Mahieux	27
17	Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeanacolony 2006 ·Retrovirology ·Sara Calattini, (unknown), Bernard Thierry, Christine Schmitt, Sylviane Bassot, Ali Saı̈b, (unknown), Antoine Gessain	32
18	Itraconazole Can be Effective in the Treatment of Sporotrichoid Leishmaniasis 2006 ·Journal of Travel Medicine ·Paola Morelli, Erika Gianelli, Sara Calattini, Mario Corbellino, Spinello Antinori, Luca Meroni	5
19	Presence of a functional but dispensable Nuclear Export Signal in the HTLV-2 Tax protein 2005 ·Retrovirology ·Sébastien Alain Chevalier, Laurent Meertens, Sara Calattini, Antoine Gessain, Lars Kiemer, Renaud Mahieux	28
20	Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa 2005 ·Retrovirology ·Sara Calattini, Sébastien Alain Chevalier, Renan Duprez, Sylviane Bassot, Alain Froment, Renaud Mahieux, Antoine Gessain	158

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact